European Commission greenlights €211 million funding for Cambridge graphene photonics spinout

University spinout, CamGraPhIC, has received the EC greenlight for €211 million funding (about £183 million) from Italy to support the development of photonic optical transceivers based on graphene.

Speak to the Human returns with a new host, and a first episode that tackles one of the biggest challenges facing organisations and leaders right now: AI adoption.

Speak to the Human returns with a new host, James Woodman.

Price Bailey announces five senior level promotions in April

The latest round of senior promotions come following the appointment of six new Partners, reflecting Price Bailey’s ongoing commitment to developing talent.

Breaking the code: Why you should check your PAYE tax code

If you have received a new tax code recently, check it. Do not assume it is correct.

Intuition is cultivated, not transcribed

Beth, at KISS, makes the case that intuition isn't a mystical trait but a biological process, one that generative AI can't replicate however sophisticated it becomes.

Baya Systems Strengthens Engineering Leadership to Accelerate Chiplet Implementation

At Baya Systems, we are focused on enabling our partners to accelerate the journey from architecture to silicon as AI and chiplet-based systems grow in complexity.

Earl fulfilling noble ambition as The EpiCentre scales fresh heights

By Tony Quested in Business Weekly 15th March: The EpiCentre at Haverhill, close to Cambridge and on the border with Suffolk and Essex, is buzzing with activity and humming with the sweet sound of success – and its rise and rise has been no accident.

The retinal delivery bottleneck: why today’s tools won’t scale

Cell and gene therapies make up a large and growing proportion of pipeline treatments for high-prevalence diseases of the retina. For these advanced therapies to deliver on their promise, most need to be delivered into the retina, overcoming significant physiological barriers. But existing retinal delivery is a slow, skilled, small-scale business: enabling patients with high-prevalence diseases…

Price Bailey announces five new Partner level appointments

Leading accountancy firm Price Bailey announces the successful appointment of five senior team members who will move into the firm’s Partner team, including two external appointments and three internal p

'Addenbrooke's saved my twin sister - and her baby': the powerful stories inspiring Addenbrooke’s Charitable Trust’s TCS London Marathon runners

Addenbrooke's Charitable Trust (ACT) has a record 18 runners in this year's TCS London Marathon. Not only that - but to date they have also raised a record £54,000 between them. To hear their stories, and to find out why they are running to raise funds for Addenbrooke's and the Rosie, see below.

Supporting busy teams with practical 90-minute Microsoft Copilot training

Help your team save time, reduce manual work, and get more from Microsoft Copilot. These 90-minute, instructor-led sessions focus on practical skills your team can start using immediately in Excel, Word and PowerPoint.

Atelerix forms strategic partnership with JH Health Ltd to expand non-cryogenic cell preservation capabilities in the Middle East

Agreement grants JH Health exclusive rights to use and distribute Atelerix’s portfolio of non-cryogenic preservation solutions in the regionExpands regional capabilities with funding for high-volume local manufacturing, as well as relevant regulatory filings and researc

CJ & L Consultancy Ltd announces strategic partnership with ISMS.online (IO) to strengthen cyber security and medical device compliance

CJ & L Consultancy Ltd, a specialist consultancy providing expert guidance in medical device quality, regulatory compliance, and information security, is pleased to announce a strategic partnership with ISMS.online, a leading provider of Information Security Management System (ISMS) software. The partnership enhances CJ & L Consultancy Ltd’s ability to support organisations seeking Cyber…

Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia™ Platform

·       Proceeds will help enhance workflows and expand single-cell functional assay portfolio

·       Brad Crutchfield joins as advisor to support early access growth and  global launch

How to break up with your IT support provider

Most organisations don’t suddenly decide to change their IT support.Nothing has failed outright, but confidence starts to slip.You’re not sure what you’re paying for anymore. Security conversations feel vague. Planning feels reactive, not reassuring.

Bio-Rad extends range of anti-idiotypic antibodies and anti-Fc mutation antibodies for bioanalysis and drug monitoring

Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications

East West Rail reveals updated designs, earlier construction of new stations, and up to five trains an hour in latest consultation

East West Railway Company (EWR Co) has today launched its latest consultation which includes updated proposals for the new railway in Cambridgeshire. Key design updates include an accelerated construction programme to deliver the benefits of the railway to communities earlier and the delivery of up to five trains an hour.

ELRIG announces inaugural US Drug Discovery Conference

• Free-to-attend event takes place at Pfizer in Cambridge, MA from 16–17 June • Drug Discovery USA 2026 to focus on emerging multifunctional small molecule and biologic approaches to drug difficult targets

OBN rebrands to BioUK in alignment with its mission to catalyse success in UK life sciences

·        The new name reflects the national reach of the UK life science membership organisation and leverages its wide and long-established portfolio of Bio-prefixed events 

ProImmune collaborates with The University of Texas Medical Branch to Advance Infectious Disease Research

Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments

VALANX Biotech establishes Scientific Advisory Board to advance ADC therapeutics

John Lambert, Morris Rosenberg and Peter de Waele appointed as Chair and members of the SAB respectivelySAB provides scientific expertise and drug development experience, supporting advancement of the Company’s GoldenSite™ conjugation platform and its LIV-1 targeting le

The gap in B2B marketing that nobody owns

Drawing on 35 years in marketing, Sarah argues there's a gap in B2B marketing that nobody quite owns. Buyers no longer work through a methodical long-list, they're increasingly handed a shortlist by an AI-generated answer, an algorithm-curated feed or a trusted peer recommendation, and being good at what you do is no longer enough to be visible.

Richard Traherne appointed as new CEO of Cambridge Consultants

Richard succeeds Monty Barlow, who has taken on the role of Global Chief Technology & Innovation Officer at Capgemini Invent.

50,000 join Cambridge Festival for ideas, debate and discovery

Cambridge turned curious, noisy and gloriously hands on this spring as the Cambridge Festival wrapped its 2026 edition with a surge of public energy, big ideas and record numbers.

Oil, Inflation, and the innovation budget question: what UK-China life sciences collaboration looks like when conditions tighten

Excellence First Enterprise Consultancy (EFEC). When oil moves sharply, life sciences people can be tempted to see it as someone else’s problem. Energy is macroeconomics; biotech and MedTech are innovation. But that separation is usually an illusion.